Sernova is developing regenerative medicine therapeutic technologies using a medical device and immune protected therapeutic cells (i.e., human donor cells, corrected human cells and stem-cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases such as insulin- dependent diabetes, blood disorders including hemophilia, and other diseases treated through replacement of proteins or hormones missing or in short supply within the body.
Sernova专注于利用医疗设备和免疫保护治疗细胞（人类供体细胞,corrected human cell和stem-cell-derived cell）开发再生医学治疗技术用于治疗慢性代谢疾病如胰岛素依赖型糖尿病,血液疾病如血友病、和其他疾病。作用机制是替代体内缺失或短缺的蛋白质或激素。
